Eleftheria E. Lamprianidou
Alexandroupoli, ESYE11, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high-risk myelodysplastic syndromes.
Journal: British journal of haematology
Published: December 28, 2025
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms.
Journal: European journal of immunology
Published: July 12, 2024
Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine.
Journal: Cancer research communications
Published: June 01, 2024
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes.
Journal: Blood cancer journal
Published: February 06, 2023
Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter.
Journal: Frontiers in oncology
Published: January 07, 2021
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression.
Journal: Genome medicine
Published: August 07, 2019
The STAT signaling profile at the single cell level reveals novel insights in the association of FOXP3+ T regulatory cells with recurrent spontaneous abortions before and after lymphocyte immunotherapy.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 11, 2019
Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigma.
Journal: Leukemia & lymphoma
Published: June 13, 2019
Last Updated: 09/26/2026